Action of magnesium sulfate in the treatment of preeclampsia-eclampsia.
- 1 September 1989
- journal article
- review article
- Published by Wolters Kluwer Health in Stroke
- Vol. 20 (9) , 1273-1275
- https://doi.org/10.1161/01.str.20.9.1273
Abstract
Recent evidence supports the concept that cerebral vasospasm is involved in the pathogenesis of eclampsia. Magnesium, which has a beneficial effect in eclampsia, may act by opposing calcium-dependent arterial constriction, thereby relieving vasospasm. Magnesium may also antagonize the increase in intracellular calcium concentration caused by ischemia and thus prevent cell damage and death. Magnesium might have a role in the treatment of cerebral vasospasm and ischemia, such as occurs in subarachnoid hemorrhage, ischemic stroke, and brain trauma.Keywords
This publication has 31 references indexed in Scilit:
- Therapeutic Use of Magnesium Sulfate in Selected Cases of Cerebral Ischemia and SeizureNew England Journal of Medicine, 1988
- A Controlled Trial of Nimodipine in Acute Ischemic StrokeNew England Journal of Medicine, 1988
- Excitotoxity and the NMDA receptorTrends in Neurosciences, 1987
- Calcium and Ischemic InjuryNew England Journal of Medicine, 1986
- Toxemia of PregnancyJournal of Computer Assisted Tomography, 1985
- Magnesium gates glutamate-activated channels in mouse central neuronesNature, 1984
- Possible treatment of pre-eclampsia with calcium channel blocking agentsMedical Hypotheses, 1983
- Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid HemorrhageNew England Journal of Medicine, 1983
- Effect of the Calcium Antagonist Nimodipine on Contractile Responses of Isolated Canine Basilar Arteries Induced by Serotonin, Prostaglandin F2α, Thrombin, and Whole BloodNeurosurgery, 1982
- The role of calcium in cell deathLife Sciences, 1981